Children as a sensitive subgroup and their role in regulatory toxicology: DGPT workshop report

M Schwenk1, U Gundert-Remy, G Heinemeyer

  • 1Federal Health Department Baden-Württemberg, Department of Toxicology, Wiederholdstrasse 15, 70174 Stuttgart, Germany, michael@schwenk.tue.uunet.de

Archives of Toxicology
|December 20, 2002
PubMed

Insights

Children may be more sensitive to toxicants than adults due to developmental and exposure factors. Public health regulations and toxicological models need refinement to better protect children from environmental chemicals and lifestyle risks.

Area of Science:

  • Environmental Health
  • Toxicology
  • Pediatrics

Background:

  • Children represent a unique subgroup in public health, potentially exhibiting higher sensitivity to toxicants than adults.
  • Differences in susceptibility stem from toxicokinetic, toxicodynamic, and exposure factors, particularly during early development.
  • Immature metabolic and renal systems in neonates, alongside organ development, contribute to specific vulnerabilities.

Purpose of the Study:

  • To highlight the need for specialized public health regulations for children.
  • To discuss the factors influencing children's toxicological sensitivity.
  • To emphasize the necessity for improved exposure models and toxicological testing for pediatric populations.

Main Methods:

  • Review of toxicokinetic and toxicodynamic differences between children and adults.
  • Analysis of age-specific exposure patterns in children, including behavioral factors.
  • Discussion of current toxicological test models and the need for infant-specific systems.

Main Results:

  • Children's sensitivity to toxicants varies with age due to developmental stages and immature physiological systems.
  • Specific behaviors in toddlers, like hand-to-mouth activity, increase exposure to environmental chemicals.
  • Existing exposure models require age-specific refinement and validation through biomonitoring.

Conclusions:

  • Toxicological sensitivity in children necessitates tailored regulatory approaches and advanced testing methodologies.
  • Improved models and infant-focused toxicological studies are crucial for accurate risk assessment.
  • Addressing lifestyle-related toxic exposures in children and adolescents is a significant public health priority.

Related Concept Videos

Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...